Amarin Corp Plc (AMRN)

[Whalatane]

The closest any CV Outcome trial I'm aware of with results anywhere near to Chas's outer range

is ................... ( left blank for U to fill in the name ).......because of a 44% reduction in the trial primary end point of all vascular events (P<0.00001), a 54% reduction in myocardial infarction (P=0.0002), a 48% reduction in stroke (P=0.002), a 46% reduction in need for arterial revascularization (P<0.001), and a 20% reduction in all cause mortality (P=0.02;

Note the P values here

Kiwi